`Case 1:01-cv-02015-RJL Document 107 Filed 03/31/06 Page 1 of 15
`
`UNITED STATES DISTRICT COURT
`
`FOR THE DISTRICT OF COLUMBIA
`
`SCIMED LIFE SYSTEMS, INC.,
`
`Plaintiff and Counterclaim-Defendant ,
`
`V0
`
`MEDTRONIC VASCULAR, INC.,
`
`Defendant and Counterclaim-Plaintiff,
`
`and
`
`ERIC C. MARTIN,
`
`Defendant and Counterclaim-Defendant.
`
`\-./\../\_/&/‘u./\.—v’\—/\—"-—/\—r’\—/\—/\—/\—n/‘-u.dH./\u/
`
`Civil Case No. 01-2015 (RJL)
`
`5%’
`MEMORANDUM OPINION
`
`(Mmchy, 2006) [# 76, 100, 102, 103]
`
`Plaintiff, Scimed Life Systems, Inc.
`
`(“Scimed”), brought
`
`this action against
`
`defendants, Medtronic Vascular, Inc. (“Medtronic”) and Eric C. Martin, underTitle 35 ofthe
`United States Code Section 146, challenging the Final Decision and Judgment ofthe Board
`ofPatent Appeals and Interferences (the "Board") ofthe United States Patent and Trademark
`Office ("USPTO") regarding Patent Interference No. 104,192 between certain patent
`
`applications for an apparatus for reinforcing a bifurcated lumen. Presently before the Court
`
`are Medtronic’s Motion for Summary Judgment, Seimed’s First and Second Motions for
`
`Summary Judgment, and Medtronic’s Motion to Compel Production of Documents and
`
`1
`
`ENDOLOGIX, INC
`EX. 1018
`
`
`
`Case 1:01-cv-02015-RJL Document 107 Filed 03/31/06 Page 2 of 15
`Case 1:01—cv—02015—RJL Document 107 Filed 03/31/06 Page 2 of 15
`
`Things. After due consideration of the parties’ submissions, the relevant law and the entire
`
`record herein, the Court finds that the Board did not erroneously affirm its Grant of the
`
`Fogarty er at]. United States Patent Application Serial No. 08/463,836 (now owned by
`
`Medtronic) Motion 12 in its July 27, 2001 Final Decision and Judgment. Accordingly, this
`
`Court affirms the Board’s Final Decision and Judgment and,
`
`therefore, GRANTS
`
`Medtronie’s Motion for Summary Judgment, DENIES Scimed’s First and Second Motions
`
`for Summary Judgment, and DENIES AS MOOT Medtronic’s Motion to Compel Production
`
`of Documents and Things.
`
`I_.
`
`BACKGROUND
`
`Plaintiff Scimed and defendant/counterclaimant Medtronic are each assignees of
`
`record oftwo different patent. applications for a bifurcated lumen invention.‘ Andrew Cragg
`
`and Michael Dake (collectively referred to as party “Cragg” in the underlying proceedings
`
`at the USPTO) filed an application with the USPTO regarding the bifurcated lumen
`
`apparatus on June 5, 1995. The application was assigned the serial number 08/461,402 (the
`
`“‘402 application”). Cragg and Dake assigned all rights in the ‘402 application to Boston
`
`Scientific Technology, Inc., which later merged into plaintiff Scimed. Scimed is now the
`
`present legal owner of the ‘402 application. Medtronic was assigned its rights in a patent
`
`application for the same invention by Thomas J. Fogarty, Timothy J. Ryan, and Kirsten
`
`Freislinger (collectively referred to as party “Fogarty” in the underlying proceedings at the
`
`The “Background” section of this Memorandum Opinion has been partially adapted from this
`I
`Court’s earlier Memorandum Opinion in Scimed Life Systems, Inc. V. Medrronic Ave Inc. , 297 F. Supp.
`2d 4 (D.D.C. 2003).
`
`
`
`Case 1:01-cv-02015-RJL Document 107 Filed 03/31/06 Page 3 of 15
`Case 1:0l—cv—02015—RJL Document 107 Filed 03/31/06 Page 3 of 15
`
`USPTO). That application was also filed with the USPTO on June 5, 1995, and assigned the
`
`serial number 08/463,836 (the “‘836 application”). Party Fogarty assigned its rights in the
`
`‘S36 application to Medtronic Aneurx, Inc., which merged into Medtronic AVE, Inc. which
`
`later became the defendant/counterclaimant Medtronic. Medtronic is now the legal owner
`
`of the ‘E336 application. Defendant/counterclaim—defendant Eric Martin owns patent No.
`
`5,575,817 (the “Martin” or “‘8 1 7 patent”), based on application 08/293,541, filed on August
`
`19, 2004.
`
`On April 23, 1998, the USPTO Board declared an interference between SciIned's
`
`patent application (the “Cragg” or “‘402 application”), Medtronids patent application (the
`
`“Fogarty” or “‘836 application”) and the Martin patent. This interference proceeding was
`
`assigned Interference No. 104,192, and is referred to as the “‘ 192 interference.” On July 2,
`
`1998, the Board set the following as the sole “count”3:
`
`An apparatus for reinforcing a bifurcated lumen comprising:
`a first section, configured to be positioned within the lumen, comprising:
`an upper limb, configured to fit within the lumen upstream of the bifurcation;
`a first lower limb, configured to extend into the first leg of said bifurcation
`when said first section is positioned in the lumen, and
`
`“The purpose of an interference proceeding is to resolve the question of priority of invention
`2
`when more than one applicant seeks a patent on substantially the same invention.” 3A-10 Donald S.
`Chisum, Chisum on Patents § 10.09[1] [a] (2006). This action was brought in federal Court pursuant to 35
`U.S.C. § 146, which allows a party dissatisfied with the decision of the Board in an interference to bring
`a civil action as long as the Board’s decision is not being appealed to the United States Court of Appeals
`for the Federal Circuit “and such appeal is pending or has been decided.” See 35 U.S.C. § 146.
`
`“A count defines the interfering subject matter. In In re Van Germs (1993), the Federal Circuit
`3
`noted that (1) ‘[a]1though claims of one or more of the parties may be identical to the count of an
`interference, the count is not a claim to an invention,’ and (2) ‘ [t]he count of an interference is merely the
`Vehicle for contesting the priority of invention and determining what evidence is relevant to the issue of
`priority.” 3A—10 Donald S. Chisum, Chisum on Patents § 10.09[3] (2006).
`
`3
`
`
`
`Case 1:0l—cv—02015—RJL Document .107 Filed 03/31/06 Page 4 of 15
`Case 1:01-cv-02015-RJL Document 107 Filed 03/31/06 Page 4 of 15
`
`a second lower limb, shorter that said first lower limb, and configured so that
`when said first section is positioned in the lumen, said second lower limb does
`not extend into a second leg of said bifurcation,
`and further comprising
`a second section configured to be positioned separately within the lumen and
`joined to said second lower limb ofthe first section, effectively extending said
`second lower limb into said second leg of said bifurcation.
`
`Cragg et‘ al. 12. Martin 12. Fogarty er al., Patent Interference No. 104,192, Paper No. 187,
`
`Final Decision and Judgment at 5-6 (United States Patent and Trademark Office, Board of
`
`Patent Appeals and Inferences July 21, 2001)(“Board’ s Final Judgment”). The purpose ofthe
`
`‘ 192 Interference was for the Board to determine who among the three parties had priority
`
`of inventorship, and was, therefore, entitled to the invention defined by the count.
`
`At the time of declaration of the interference, party Cragg was accorded by the
`
`USPTO the benefit of the filing dates of two European patent applications (i.e. February 9
`
`and June 10, 1994), which had been filed by a French Company known as Mintec SARL.
`
`At the time of declaration of the interference, party Fogarty, on the other hand, was accorded
`
`by the USPTO the benefit of the earlier filing date of U.S. patent application 08/255,681:
`
`i.e. on June 8, 1994. Thus, at the start of the interference, party Cragg was designated the
`
`“senior party,”4 on the basis of the accorded benefit date ofFebruary 9, 1994. On March 13 ,
`
`2000, party Fogarty filed a preliminary motion attacking the benefit accorded party Cragg to
`
`“In an interference proceeding, the first party to file is designated as the ‘senior party’ and all
`4
`other parties as ‘junior.’ The junior party bears the burden of going forward with evidence as to actual
`reduction to practice prior to the senior party's filing date or conception prior to the senior party's filing
`date plus continuous and reasonable diligence during the critical period. If the senior party desires to
`show a date of conception or reduction to practice prior to his filing date, he hears the burden of going
`forward with evidence.” - 3A—10 Donald S. Chisurn, Chisum on Patents § 10.03[1][c][ii] (2006).
`
`4
`
`
`
`Case 1:01-cv-02015-RJL Document 107 Filed 03/31/06 Page 5 of 15
`Case 1:0l—cv—02015—RJL Document 107 Filed 03/31/06 Page 5 of 15
`
`I. the filing dates of the two European applications and sought to be made the senior party in
`
`the interference. On April 7, 2000, the Board granted party Fogarty’s preliminary motion 12,
`
`declaring party Fogarty the senior party in the interference and party Cragg and party Martin
`
`as junior parties in the interference. Cmgg ez‘ al. v. Martin v. Fogarty ez‘ al., Patent
`
`Interference No. 104,192, Paper No. 130, Decision on Party Cragg’s Motion to Correct the
`
`Preliminary Statement and on Party Fogarty’s Preliminary Motion No. 12 at 7 (United States
`
`‘Patent and Trademark Office, Board of Patent" Appeals and Inferences April 24,
`
`2000)(“Deeision on Preliminary Motion No. 12”). In that same opinion, the Board denied
`
`party Cragg’s motion to amend its preliminary statement to name Michael D. Dake and
`
`Andrew H. Cragg as co-inventors of the party Cragg invention.
`
`Id. at 7. Party Cragg
`
`requested reconsideration ofthat decision claiming that the Board had erred in its ruling and
`
`' claimed that Mintec filed the European applications as assignees of both Dake and Cragg,
`
`the co—inVentors of the subj ect matter of the patent application.
`
`On April 24, 2000, the Board issued a Decision on Reconsideration denying the
`
`request for reconsideration on the basis that Dal<e’s assignment of his rights in the patent
`
`application came after the filing of the European application and that 35 U.S.C. § 119 could
`
`not be interpreted to allow Mintee the benefit of priority With this subsequent assignment of
`
`' ‘rights. Cragg er al. v. Martin 12. Fogarly ea‘ al., Patent Interference No. 104,192, Paper No.
`
`138, Decision on Reconsideration (United States Patent and Trademark Office, Board of
`
`Patent Appeals and Inferences April 24, 2000)(“Board’s Decision on Reconsideration”). In
`
`
`
`Case 1:01-cv-02015-RJL Document 107 Filed 03/31/06 Page 6 of 15
`Case 1:0l—cv—02015—RJL Document 107 Filed 03/31/06 Page 6 of 15
`
`its decision, the Board interpreted Title 35 of the United States Code Section 119 to require
`
`that “the previously filed foreign application must have been filed by the person or one who
`
`was, at the time of filing of the previously filed foreign application, already a legal
`
`representative or assign of that person.” Id. at 3. The Board went on to state that their
`
`interpretation of Section 119 “is necessary to ensure a link between the presently involved
`
`application and the earlier filed foreign application with respect to the particular inventor.
`
`A contrary interpretation would cause entitlement to benefit to be negotiable as a commodity
`
`between unrelated entities.” Id. In essence, the Board rejected party Cragg’s position on the
`
`assignment of rights to the patent and stated:
`
`We are unpersuaded that an assigmnent ofownership rights changes on whose
`behalf an application was previously already filed. It would appear that only
`filings subsequent to the assignment of rights from Michael D. Dake can be
`deemed as being executed or performed on his behalf.
`
`Id. at 5. Party‘ Cragg requested a final hearing for review of the Board’s decision claiming
`
`that the Board had erroneously interpreted Section 119 and that Dake and Cragg were co-
`
`inventors and that Mintec SARL was the assignee of both Dake and Cragg for the subject
`
`matter invention even though the assignments occurred after the European patent applications
`
`were filed. See id at 11-23. On July 27, 2001, the Board issued its Final Decision and
`
`Judgment. See Board’s Final Judgment.
`
`In its Final Judgment, the Board adopted its earlier interpretation of 35 U.S.C.§ 119.
`
`Id. at 9. The Board cited Vogel v. Jones, 486 F.2d 1068, 1072 (C.C.P.A. 1973), for the
`
`proposition that “a foreign application made by the assignee of a U.S. applicant, on behalf
`
`6
`
`
`
`Case 1:01-cv-02015-RJL Document 107 Filed 03/31/06 Page 7 of 15
`Case 1:0l—cv—02015—RJL Document 107 Filed 03/31/06 Page 7 of 15
`
`of one other that the United States inventor, is irrelevant to the rights of priority of the U.S.
`
`inventor.” -Id. at 10. The Board stated that the “plain statutory language” of Section 119
`
`does not put “an assignee in the same position as if it were a ‘legal representative’ or ‘assign’
`
`ofthe inventor at a previous time when a foreign application for the same invention was filed
`
`by that assignee.” Id. at 12. The Board found that Dake assigned his invention to Mintec,
`
`Inc. more than two years after the filing of the two European patent applications. Id. at 11-
`
`12. The Board went on to state, that even assuming that party Cragg’ s preliminary statement
`
`identified both Cragg and Dake as co-inventors of the subject matter of the count, that fact
`
`would not help party Cragg as “Cragg also did not assign his rights to Mintec, Inc. until
`
`after” the two European patent applications were filed.
`
`Id. at 20. The Board found that
`
`“MINTEC SARL was not an assign of either Michael D. Dake nor Andrew H. Cragg when
`
`it filed European applications EP944oo284.9 and EP944013069.” Id. For those reasons,
`and others, the Board found that there was no error in the granting of party Fogarty’s
`
`preliminary motion 12. Id. at 23.
`
`On September 25, 2001, Scimed filed this appeal under Title 35 of the United States
`
`Code Section 146, seeking this Conrt’s review of the Board’s Final Decision and Judgment
`
`in the ‘I92 Interference. The parties to this action entered into a stipulation and order
`
`limiting the issues in this case. The stipulated issue to be resolved is:
`
`Whether the Board erroneously affirmed its Grant ofF0garty er al. (Medtronic)
`Motion 12 in its July 27, 2001 Final Decision denying Cragg er al. (Scimed)
`benefit of the February 9, 1994 filing date of its European application No.
`
`
`
`Case 1:01-cv-02015-RJL Document 107 Filed 03/31/06 Page 8 of 15
`Case 1:0l—cv—02015—RJL Document 107 Filed 03/31/06 Page 8 of 15
`
`944002849 as a date ofinvention for the subject matter ofthe single count in
`Interference No. 104,192.
`
`(See Stipulation and Order entered March 25, 2004, Dkt. 50.) On-July 22, 2005 , both parties
`
`moved for summary judgment on this remaining issue and provided the Court with exhibits
`
`supporting their positions.
`
`_I_L
`
`STANDARD OF REVIEW
`
`Summary Judgment is appropriate when the pleadings and the record demonstrate that
`
`("there is no genuine issue as to any material fact and that the moving party is entitled to a
`
`' judgment as a matter of law." F-ed. R. Civ. P. 56(0); see also Celotex v. Catrett, 477 U.S.
`
`317, 322 (1986); Diamond v. Atwood, 43 F.3d 1538, 1540 (D.C. Cir. 1995). To determine
`
`' which facts are "material," a Court must look to the substantive law on which each claims
`
`'
`
`rests. Anderson 12. Liberty Lobby, Inc., 477 U.S. 242, 248 (1986). A "genuine issue" is one
`
`Whose resolution could establish an element of a claim or defense and, therefore, affect the
`
`outcome of the action. Celotex, 477 U.S. at 322; Anderson, 477 U.S. at 248. Additionally,
`
`to be a genuine issue of fact, it must be supported by sufficient admissible evidence such that
`
`I a reasonable trier of fact could find for the nonmovant. See Laningham v. United States
`
`"Navy, 813 F.2d 1236, 1242-43 (D.C. Cir. 1987).
`
`The moving party bears the initial burden of "identifying those portions of the
`
`‘pleadings, depositions, answers to interrogatories, and admissions on file, together with the
`
`affidavits, if any,’ which it believes demonstrates the absence of a genuine issue of material
`
`6' fact." See Celotex, 477 U.S. at 323. In order to prevail on its motion for summaryjudgment,
`
`8
`
`
`
`Case 1:01-cv-02015-RJL Document 107 Filed 03/31/06 Page 9 of 15
`Case 1:O1—cv—O2015—RJL Document 107 Filed 03/31/06 Page 9 of 15
`
`the rnovant must Show that the nonmovant "fai1[ed] to make a showing suffi cient to establish
`
`the existence of an element essential to that party's case, and on which that party will bear
`
`the burden of proof at trial." Id. at 322.
`
`In opposing summary judgment,
`
`the “nonmoving party [must] go beyond the
`
`pleadings and by [its] own affidavits, or by the depositions, answers to interrogatories, and
`
`‘admissions on file,’ designate ‘specific facts showing that there is a genuine issue for tria .’”
`
`Id. at 324. The Court must view the facts in the light most favorable to the nonmovant,
`
`giving the nonmovant the benefit of all justifiable inferences derived from the evidence in
`
`the record. Anderson, 477 U.S. at 255 (1986). The nonmovant,.however, must establish
`
`more than "the mere existence of a scintilla of evidence" in support ofits position. Id. at 252.
`
`In order for Scimed to prevail on summary judgment, Scimed must put forth evidence
`
`and legal support that meets the standard of proof this Court is required to apply when
`
`reviewing decisions of the Board of Patent Appeals and Interferences of the USPTO.
`
`In
`
`determining whether or not the Board erroneously affirmed its Grant of party Fogarty’s
`
`preliminary motion 12 and, therefore, erroneously awarded priority for the subj ect matter of
`
`the single count in the ‘ 192 Interference to Medtronic, this Court will apply the standard of
`
`proof set forth in Morgan 12. Daniels, in that when a decision has been made by the Patent
`
`Office in an action contesting priority of invention, “the decision there made must be
`
`accepted as controlling upon that question of fact in any subsequent suit between the same
`
`parties, unless the contrary is established by testimony which in character and amount carries
`
`
`
`Case 1:01-cv-02015-RJL Document 107 Filed 03/31/06 Page 10 of 15
`Case 1:01—cv—02015—RJL Document 107 Filed 03/31/06 Page 10 of 15
`
`thorough conviction.” Morgan, 153 U.S. 120, 125 (1894) (emphasis added) (determining
`
`the standard ofreview for a Patent Office decision when no additional evidence was put forth
`
`to the Circuit Court). Our Circuit Court, in United States v. Szuecs, 240 F.2d 886 (D.C. Cir.
`
`1957), upheld the Morgan standard of proof that must be applied by a District Court when
`
`reviewing a decision of the Patent Office pursuant to 35 U.S.C. § 146.
`
`“To reach a
`
`conclusion contrary to that of the Patent Office,” the Morgan standard requires the evidence
`
`to carry “‘thorough conviction.” Szuecs, 240 F.2d at 887 (citing Morgan, 153 U.S. at 125)
`
`(reversing and rernanding the case to the District Court to apply the correct standard of
`
`proof).
`
`Another District Court Judge of this Court reaffirmed the application of Morgan in
`
`reviewing Patent Office cases under 35 U.S.C. § 146. Anderson v. Anderson, 403 F. Supp.
`
`834, 844-45 (D.D.C. 1975) (affirming the decision ofthe Board ofPatent Interferences after
`
`reviewing the full administrative record and hearing additional oral testimony), a)j”d, 543
`
`F.2d 1389 (D.C. Cir. Nov. 11, 1976).
`
`In Anderson, Judge John H. Pratt found that the
`
`‘fPatent Office is entitled to a presumption of correctness and regularity.” Id. at 844 (citing
`
`Vogel V. Jones, 346 F. Supp. 1005 (D.D.C. 1972). Judge Pratt went on to reiterate that the
`
`District Court could not overturn the Board’s decision unless the evidence put forth by the
`
`movant carried “thorough conviction,” and “[t]he ‘thorough conviction’ standard imposes
`
`a heavy burden on plaintiffs in an action under 35 U.S.C. § 146,” and that “[a] mere
`
`preponderance of the evidence is not enough to justify reversing the Patent Office.” Id. at
`
`10
`
`
`
`Case 1:01-cv-02015-RJL Document 107 Filed 03/31/06 Page 11 of 15
`Case 1:O1—cv—O2015—RJL Document 107 Filed 03/31/06 Page 11 of 15
`
`845. For the following reasons, the Court finds that the plaintiff has failed to meet its heavy
`
`burden, and concludes that the Board did not err in its interpretation of Section 119.
`
`_I_1_1_, ANALYSIS
`
`A.
`
`Inter retation 0 35 U.S.C.
`
`119
`
`In the Board’s Final Judgment, it reaffirmed its earlier decision that the “plain
`
`statutory language” of Section 119 requires that the person who filed the foreign patent
`
`application must have been a legal representative or assign of the person who filed the patent
`
`application in the United States at the time that the foreign patent application was filed?
`
`Board’s Final Judgment 9-10. The pertinent part of Section 119 reads:
`
`(a) An application for patent for an invention filed in this country by any
`person‘ who has, or Whose legal representatives or assigns have, previously
`regularly filed an application for a patent for the same invention in a foreign
`country which affords similar privileges in the case of applications filed in the
`United States or to citizens of the United States, or in a WTO member country,
`shall" have the same effect as the same application would have if ‘filed in this
`country on the date on which the application for patent for the same invention
`Was firstfiled in such foreign country.
`
`35 U.S.C. § l19(a). The Board’s interpretation of Section 119 is supported by Vogel v.
`
`Jones, 486 F.2d 1068 (C.C.P.A. 1973). See Board’s Final Decision 10-11.
`
`In Vogel, the
`
`Court of Customs and Patent Appeal, the predecessor to the current Court ofAppeals for the
`
`Federal Circuit, read Section 119 to mean “that an applicant for a United States patent can
`
`rely for priority on the ‘first filed’ application by an assignee on his behalf.” 486 F.2d at
`
`While counsel for Scimed is quick to point out its own grazrnmatical analysis of Section 119
`5
`without citing to any grammar reference guide, the Court notes that it is quite capable of reading the
`statute, interpreting the language of the statute, researching the case law pertaining to the statute and
`-applying that law to the present action.
`
`11
`
`
`
`Case 1:01-cv-02015-RJL Document 107 Filed 03/31/06 Page 12 of 15
`Case 1:O1—cv—O2015—RJL Document 107 Filed 03/31/06 Page 12 of 15
`
`1072. In order for the foreign patent application to be filed on behalf of the United States
`
`applicant, the person filing the foreign application mustbe an assignee orilegal representative
`
`at the time that the foreign application was filed. Id. If the foreign applicant was allowed
`
`to become the legal representative or assign of the United States applicant after the foreign
`
`application was filed, it would be impossible for the foreign application to have been filed
`
`on the behalfof the United States applicant. If the Board or this Court held otherwise, the
`
`right of priority could be, as the Board noted, traded or sold as a commodity to the highest
`
`bidder. See Board’s Decision on Reconsideration 3; Board’s Final Decision 9. Therefore,
`
`this Court does not find that the Board erred in its interpretation of Section 119 and Scimed
`
`has neither cited any precedent or legislative history that would Warrant interpreting the
`
`statute otherwise?
`
`Sciined argues that the Board’s construction of Section 119 is inconsistent with the Paris
`6
`Convention for the Protection of Industrial Property, openedfor signature Mar. 20, 1883, as amended at
`Stockholm, July 14, 1967, 21 U.S.T. 1630, 828 U.N.T.S. 305 (“Paris Convention”), and asks this Court
`to find that the Board’s erroneously construed Section 119 as the Board’s construction is inconsistent
`with and violates Arti-cle 4 of the Paris Convention. While Section 119, and its predecessor R.S. 4887,
`were enacted in order to implement Article 4 of the Paris Convention, Vogel, 486 F.2d at 1072, the
`Board’s construction of Section 119, which this Court finds correct, does not violate and is not
`inconsistent with the Paris Convention. The Paris Convention is not self-executing and, therefore, the
`U.S. was free to implement the Paris Convention in the manner and form that Congress deemed
`appropriate. In re Dr. Matthais Ruth, 402 F.3d 1207, 1209-10 (Fed. Cir. 2005'). Congress executed
`Article 4 of the Paris Convention first with R.S. 48 87, and then with Section 119, and Section l_l9
`requires that in order to claim a right of'pri'ority'in a foreign application, the foreigi application must
`have been fileclfby the.U.S. applicant or a person or entity who was a legal representative or assign ofthe
`U.S. applicant a_t the "time that the foreign application was filed- The concern expressed by Scirned that
`upholding the Bo'ard?s- construction of Section 119 would have in foreign countries is conjecture and
`“based on pure speculation.” See Kawai v. Meflesrics, 480 F.2d 880, 889 (C.C.P.A. 1973).
`
`12
`
`
`
`Case 1:01-cv-02015-RJL Document 107 Filed 03/31/06 Page 13 of 15
`Case 1:01—cv—02015—RJL Document 107 Filed 03/31/06 Page 13 of 15
`
`Q Review of Board ’s Decision
`
`Having found that the Board did not err in its reading and interpretation of Section
`
`119," the question remains whether the Board erred in granting Medtronic’s preliminary
`
`motion 12 seeking to deny Scimed the benefit of the filing date of its European patent
`
`applications.
`
`It did not. While a review by this Court of a Board’s Final Decision is a
`
`“hybrid of an appeal and a trial de novo” because the Court considers evidence before the -
`
`Board “as well as evidence that was not before the Board,” Winner Int? Royalty Corp. 12.
`
`Wang, 202 F.3d 1340, 1345 (Fed. Cir. 2000) (quoting Esree Lauderfnc. 12. L ’Orea[, S.A., 129
`
`F.3d 588, 592 (Fed. Cir. 1997)), it-nonetheless must treat the Board’s decision as controlling
`
`“unless the contrary is established by testimony which in character and amount carries
`
`thorough conviction.” Morgan, 153 U.S. at 125.
`
`Scimed argues that the ‘284 European application Was either filed on Dake's behalf
`
`-' “pursuant to the constructive trust imposed upon that application” when Mintec SARL filed
`
`'1 :'the application, or a theory of an equitable assignment to party Cragg. (Scimed's Mem. of
`
`' P&A in Opp'n to Medtronic's Mot. For Summ. J. 29, 35-36 (“Scimed's Opp'n”); Mem. of
`
`P&A in Supp. of Scimed's Second Mot. For Summ J. That Scimed is Entitled to the Priority
`
`of Its EP ‘284 Application Even Under the Board's Construction of 35 U.S.C. § 119(a) ) 31-
`
`33 (“Scimed's Second Mot. For Summ. J As this Court earlier recognized, “[t]he Federal
`
`' Circuit in Conservolite [Inc., v. Widmayer] held that a party's failure to raise the issue in a
`
`preliminary motion notoniy precluded it not from raising the matter at the final hearing, but
`
`13
`
`
`
`Case 1:01-cv-02015-RJL Document 107 Filed 03/31/06 Page 14 of 15
`Case 1:01—cv—02015—RJL Document 107 Filed 03/31/06 Page 14 of 15
`
`also precluded district Court review.” Scimedlzfe Systems, Inc. v. Medz‘r0m'cA VE, Inc. , 297
`
`F. Supp. 2d 4, 8 (D.D.C. 2003) (citing Conservolire, Inc. v. Widmayer, 21 F.3d 1098, 1102
`
`(Fed. Cir. 1994)). The Federal Circuit has stated that “[i]n order for an issue to have been
`
`raised adequately so that it qualifies for consideration in a § 146 proceeding, the issue should
`
`I have been raised as specified in the PTO's interference rules, for example, through
`
`preliminary motions, motions to correct inventorship, miscellaneous motions, belated
`
`motions delayed for good cause, or oppositions to these motions.” Conservolite, 21 F.3d at
`
`1 102. Therefore, Scimed is precluded from arguing that the Board erred in denying priority
`
`to Scirned either under the nevvfound constructive trust or equitable assignment theories
`
`I advanced before this Court.
`
`Thus, applying the Morgan standard ofproofto this review and not having conducted
`
`" a de novo review as in Winner, the Court finds that Scimed has not presented sufficient
`
`T evidence that Mintec SARL was either the legal representative or assign of Dake or Cragg
`
`' at the time that the relevant European patent applications were filed. Accordingly, party
`
`' Cragg and Scimed cannot claim the benefit of priority of the European patent applications.
`
`I‘ "Therefore, this Court finds that the Board did not err in its granting of party Fogarty’s
`
`'(Medtonic’s) motion No. 12 which denied Cragg er al. (Scimed) the benefit of the earlier
`
`filing date ofEuropean application No. 944002849 and affirrns the Board’ s award ofpriority
`
`_ to Fogarty er al. (Medtronic) in its July 27, 2001 Final Decision and Judgment.
`
`14
`
`
`
`Case 1:01-cv-02015-RJL Document 107 Filed 03/31/06 Page 15 of 15
`Case 1:01—cv—02015—RJL Document 107 Filed 03/31/06 Page 15 of 15
`
`LL/_.
`
`CONCLUSION
`
`For the foregoing reasons, the Court GRANTS defendant and counterclaim-plaintiff
`
`I Medtronic’s Motion for Summary Judgment [#100]; DENIES Plaintiff and counterclaim-
`
`defendant Scimed’s First Motion for Summary Judgment [#102]; DENIES Plaintiff and
`
`counterciaim—defendant Scimed’s- Second Motion for Summary Judgment [#103]; and
`
`DENIES AS MOOT defendant and counterclaim-plaintiff Medtronic’s Motion to Compel
`
`Production of Documents and Things [#76]. An order consistent with this decision
`
`accompanies this Memorandum Opinion.
`
`/.
`
`RICHARD .
`
`ON
`
`United States District Judge
`
`15